| 发明名称 |
USE OF CCR5 ANTAGONISTS ALONE OR IN COMBINATION THERAPY FOR THE TREATMENT OF CANCER |
| 摘要 |
The present invention relates to CCR5 antagonists for use in the treatment of cancer, either in monotherapy or in combination therapy. The invention also relates to methods for determining whether a subject suffering from cancer benefits from an ongoing therapeutic treatment with a CCR5 antagonist or whether a subject suffering from cancer will benefit from a planned therapeutic treatment with a CCR5 antagonist. |
| 申请公布号 |
WO2016066634(A2) |
申请公布日期 |
2016.05.06 |
| 申请号 |
WO2015EP74850 |
申请日期 |
2015.10.27 |
| 申请人 |
RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG |
发明人 |
HALAMA, NIELS;JÄGER, DIRK;ZOERNIG, INKA;GRABE, NIELS |
| 分类号 |
A61K39/395;A61K31/337;A61K31/46;A61K31/513;A61K31/519;A61K31/555;A61K31/7068;A61K35/00;A61K35/04 |
主分类号 |
A61K39/395 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
